Contact Us
Drug Search Results
More Filters [+]

Menotropin

Alternative Names: menotropin
Latest Update: 2024-05-10
Latest Update Note: PubMed Publication

Product Description

a urine derivated compound (Menopur, Ferring), which contains both LH and FSH. (Sourced from: https://clinicaltrials.gov/ct2/history/NCT03737253?V_1=View)

Mechanisms of Action: FSH Binder

Novel Mechanism: Yes

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Brazil | Bulgaria | Chile | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Egypt | Estonia | France | Germany | Hungary | Indonesia | Ireland | Italy | Latvia | Norway | Pakistan | Philippines | Portugal | Romania | Russia | Spain | Sweden | Tunisia | Turkey | United Arab Emirates | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Ferring
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Menotropin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
SHOview

N/A

Completed

Ovarian Hyperstimulation Syndrome

2014-05-01

Recent News Events

Date

Type

Title

05/10/2024

PubMed

 Pulsatile gonadotropin releasing hormone therapy for spermatogenesis in congenital hypogonadotropic hypogonadism patients who had poor response to combined gonadotropin therapy.

03/01/2024

PubMed

 The effect of human menopausal gonadotropin and equine chorionic gonadotropin on the reproductive performance of treated ewes with short-term progesterone injections and sponge during the non-breeding season.

09/01/2023

PubMed

 [Clinical efficacy of Xuanju compound capsule combined with urofollitropin in the treatment of patients with idiopathic oligoasthenozoospermia].

07/15/2021

News Article

 Advancements in Medicine Leads to Growth in Demand for Sickle Cell Disease Treatment; Global Market is Expected to Reach US$ 3.3 billion by 2031

07/06/2021

News Article

 Anti-adrenergic Agent Market Global Sales are Expected to Grow at a CAGR of 5.1% through 2031

07/01/2021

News Article

 Menotropin Market Sales are Expected to Grow at a CAGR of 5.5% through 2031

06/29/2021

News Article

 Cell Lysis Market is Favored by Increased R&D Activities; Global Sales are Expected to Reach US$ 9 billion by 2031

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions